Neurogene Inc
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurogene Inc and other ETFs, options, and stocks.About NGNE
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
NGNE Key Statistics
Stock Snapshot
Neurogene Inc(NGNE) stock is priced at $28.94, giving the company a market capitalization of 453.8M. It carries a P/E multiple of -6.14.
On 2026-05-06, Neurogene Inc(NGNE) stock moved within a range of $27.47 to $29.17. With shares now at $28.94, the stock is trading +5.4% above its intraday low and -0.8% below the session's peak.
Trading volume for Neurogene Inc(NGNE) stock has reached 142.68K, versus its average volume of 151.12K.
Over the past 52 weeks, Neurogene Inc(NGNE) stock has traded between a high of $37.27 and a low of $11.77.
Over the past 52 weeks, Neurogene Inc(NGNE) stock has traded between a high of $37.27 and a low of $11.77.
Analyst ratings
100%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.